Citation: Df. Smee et al., COMBINATION OF ANTIVIRAL IMMUNOTOXIN AND GANCICLOVIR OR CIDOFOVIR FORTHE TREATMENT OF MURINE CYTOMEGALOVIRUS INFECTIONS, Antiviral research, 32(3), 1996, pp. 165-171
Citation: Bb. Barnett et al., SELECTIVE CYTOTOXICITY OF RICIN A CHAIN IMMUNOTOXINS TOWARDS MURINE CYTOMEGALOVIRUS-INFECTED CELLS, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 470-472
Citation: Bb. Barnett et al., SELECTIVE CYTOTOXICITY TOWARDS CYTOMEGALOVIRUS-INFECTED CELLS BY IMMUNOTOXINS CONSISTING OF GELONIN LINKED TO ANTICYTOMEGALOVIRUS ANTIBODY, Antiviral research, 28(1), 1995, pp. 93-100
Authors:
SMEE DF
BARNETT BB
SIDWELL RW
REIST EJ
HOLY A
Citation: Df. Smee et al., ANTIVIRAL ACTIVITIES OF NUCLEOSIDES AND NUCLEOTIDES AGAINST WILD-TYPEAND DRUG-RESISTANT STRAINS OF MURINE CYTOMEGALOVIRUS, Antiviral research, 26(1), 1995, pp. 1-9
Authors:
SMEE DF
SUGIYAMA ST
SIDWELL RW
BARNETT BB
Citation: Df. Smee et al., EFFECTS OF MONOCLONAL-ANTIBODY COMBINED WITH GANCICLOVIR OR -1[3-HYDROXY-(2-PHOSPHONYLMETHOXY)-PROPYL]CYTOSINE AGAINST MURINE CYTOMEGALOVIRUS INFECTIONS IN CELL-CULTURE AND IN SEVERE COMBINED IMMUNODEFICIENT MICE, Chemotherapy, 41(2), 1995, pp. 141-148